My Research – Session 5: Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation

Session 5 (Wednesday 15th September at 19:00 BST) in Collaboration with COSACPG

 

 

Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/

 

We would like to invite you to join our  ‘My Research’ sessions. These sessions are delivered by members that have undertaken an audit or evaluation. They will spend 10 minutes describing their career pathway and the next 10 minutes about the research methods that they used. There will be time for detailed questions following the talk. These sessions will enable members to learn about quantitative and qualitative methods and the learning may guide and help you in your future projects. We also hope that this will be a good opportunity to learn about different career pathways in cancer pharmacy.

 

The session will be delivered by: Julian Lindsay

Julian Lindsay (BPharm, MClinPharm, PhD candidate) is a Bone Marrow Transplant (BMT) Pharmacist at Royal North Shore Hospital in Sydney, Australia and a research fellow and PhD candidate at the National Center for Infection in Cancer (NCIC) at the Peter MacCallum Cancer Centre in Melbourne, Australia. His research interest is prevention of infections in patients with blood cancers and those undergoing bone marrow transplants including cytomegalovirus, Epstein-barr virus and invasive fungal infections. He will be conducting research full time in Seattle, USA, at The Fred Hutchinson Cancer Research Centre, in conjunction with the Peter MacCallum Cancer Centre in Melbourne, Australia. The research aims to address the critical knowledge gaps related to the optimization of antifungal prophylaxis, involving large scale clinical studies of patient outcomes when using new antifungal medications, as well as optimisation of antifungal dosing using pharmacogenomic testing to improve outcomes.

 

 

 

 

 

 

 

 

The session will be chaired by: Nick Duncan

Nick is an Academic Practitioner in the School of Pharmacy at the University of Birmingham and Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Foundation Trust, UK. He qualified as a pharmacist in 1994 and has spent most of his career to date working in oncology and haematology, particularly in the area of haematopoietic stem cell transplantation. He qualified as an independent prescriber in 2010 and has an active prescribing role in a variety of haematology clinics. Areas of research interest include medicines adherence, chronic myeloid leukaemia and antifungal stewardship.

 

Nick is Secretary of the UK BMT Pharmacists Group – https://www.bopa.org.uk/membergroups/affiliated-groups/bmt-group/

 

 

 

 

 

Please Note:

-Webinars will start at 19:00 BST and will last about 30 minutes to 1 hour

-The Zoom link for the webinar will be sent on the day of the event around 17:30pm (if you would like the link before this time please email [email protected])

-Webinars are FREE to access for BOPA Paid and BOPA FREE Members

-Webinars will be recorded and appear in the BOPA eLearning section of the website via this LINK

 

 

Pinkie, Bastiaan and Alkesh
BOPA Audit & Research and Education &Training Sub-Committee Chairs

Latest News

By BOPA Committee on 3rd May 2025

Let’s Talk About SACT podcast has been featured in the TOP 40 pharmacology Podcasts worldwide

The BOPA podcast team (Michal Sladkowski, Chiara Creed and Eleanor Meerstadt) are thrilled to share that the Let’s Talk About SACT podcast has been featured in the TOP 40 pharmacology…

Read article
By BOPA Education & Training Subcommittee on 3rd May 2025

NEW eLearning module for Myeloma now live

Dear BOPA members,   The Education and Training subcommittee are pleased to announce that our new e-learning module for myeloma is now live on the BOPA website. The module can…

Read article
By BOPA Research Committee on 27th April 2025

SURVEY: Understanding Clinicians’ perceptions of a Decision Support tool for Lung Cancer Treatment

Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…

Read article
By BOPA on 27th April 2025

Further monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…

Read article